Advisory Resource Group

Position in LLY — ELI LILLY & Co

CIK 1764968 Tulsa, OK

Position in LLY

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$2,021,039

+$1,455,381 QoQ

Shares Held

1,685

+174.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.72%

of 13F equity value

Holder Rank

#2,491

of 4,605 holders

Holding Since

Sep 2020

17 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Advisory Resource Group holds $5,416,660 across 5 Drug Manufacturers - General names. LLY ranks #1 (37.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	1,685	$2,021,039
2	NVS	Novartis AG	9,787	$1,533,818
3	AZN	Astrazeneca PLC	6,819	$1,293,018
4	ABBV	AbbVie Inc.	1,136	$285,863
5	JNJ	Johnson & Johnson	1,114	$282,922

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,021,039	1,685	+174.0%	Shares	Sole	2026-07-14
2026-03-31	$565,658	615	+0.5%	Shares	Sole	2026-05-15
2025-12-31	$657,704	612	-0.2%	Shares	Sole	2026-02-12
2025-09-30	$467,719	613	-69.6%	Shares	Sole	2025-10-22
2025-06-30	$1,569,973	2,014	+4.2%	Shares	Sole	2025-08-08
2025-03-31	$1,595,658	1,932	+2.2%	Shares	Sole	2025-04-21
2024-12-31	$1,459,852	1,891	+12.3%	Shares	Sole	2025-01-28
2024-09-30	$1,491,922	1,684	-2.8%	Shares	Sole	2024-11-20
2024-06-30	$1,568,118	1,732	+3.1%	Shares	Sole	2024-07-24
2024-03-31	$1,306,972	1,680	-2.9%	Shares	Sole	2024-05-17
2023-12-31	$1,008,451	1,730	+182.7%	Shares	Sole	2024-01-11
2023-09-30	$328,723	612	0.0%	Shares	Sole	2023-12-05
2023-06-30	$287,015	612	-0.5%	Shares	Sole	2023-07-11
2023-03-31	$211,203	615	+0.7%	Shares	Sole	2023-05-15
2022-12-31	$223,528	611	-74.1%	Shares	Sole	2023-01-27
2020-12-31	$397,955	2,357	0.0%	Shares	Sole	2021-02-23
2020-09-30	$348,883	2,357	—	Shares	Sole	2020-12-09
No filing history on record for this holder in this stock.